SCHEMBL4660438

SCHEMBL4660438

O=[N+]([O-])c1cnc(OCCC2CCCN2)c(I)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6629632 0.74 SMN1; SMN2 (0.41)
SCHEMBL27828547 0.74 LTA4H (0.50)
SCHEMBL27589827 0.73 CHRNB2 (0.51)
SCHEMBL14334241 0.72 LTA4H (0.47)
SCHEMBL27884428 0.71 ALDH1A1 (0.44)
SCHEMBL27731073 0.71 S1PR4 (0.48)
SCHEMBL3377453 0.70 KMT2A (0.44)
SCHEMBL4659282 0.70 SMN1; SMN2 (0.48)
SCHEMBL8983349 0.69 MKNK1 (0.42)
SCHEMBL8554512 0.69 CHRNB4 (0.63)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2004627-A2 3-PYRIDINYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2008-12-24 EP disclosed
WO-2007120600-A2 3-PYRIDINYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2007-10-25 WO disclosed